Associated Papers
Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications.
Toh M et al.
The Oncologist, 2021
Homologous recombination, cancer and the 'RAD51 paradox'.
Matos-Rodrigues G et al.
Nar Cancer, 2021
Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors.
Pasculli B et al.
Frontiers in Oncology, 2020
32903519 (PubMed )
Supplement: Table_1.xlsx › Supplemental_Table_7_
Characterization of a potent dominant negative mutant variant of Rad51 in Ustilago maydis.
Sutherland JH et al.
Dna Repair, 2019
Variation in RAD51 details a hub of functions: opportunities to advance cancer diagnosis and therapy.
van der Zon NL et al.
F1000research, 2018
Defects in recombination activity caused by somatic and germline mutations in the multimerization/BRCA2 binding region of human RAD51 protein.
Silva MC et al.
Dna Repair, 2017
Select a paper to view details